301246.SZ · 宏源药业
China A-shares · RS rating 16 · As of 2026-10-14
| Price | 16.44 CNY |
|---|---|
| 1-day change | -3.4% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 32 / 14 / 81 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 18 / 9 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -9.2% |
| Distance from 52-week high | +52.2% |
| Market cap (USD) | $1.1B |